NCT02135510View on ClinicalTrials.gov

MEtoclopramide, DExamethasone or Axoli to Prevent or Delay Chemotherapy-induced Nausea and Vomiting in Moderately Emetogenic Non-AC-based Chemotherapy

PHASE3CompletedINTERVENTIONAL
Enrollment

249

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

March 1, 2019

Study Completion Date

March 1, 2019

Conditions
Solid Tumors
Interventions
DRUG

metoclopramide

DRUG

dexamethason

DRUG

palonosetron

Trial Locations (7)

1815 JD

Medisch Centrum Alkmaar, Alkmaar

1186 AM

Ziekenhuis Amstelland, Amstelveen

1782 GZ

Gemini Ziekenhuis, Den Helder

1213 XZ

Tergooiziekenhuizen, Hilversum

1441 RN

Waterland Ziekenhuis, Purmerend

1502 DV

De Heel - Zaans Medisch Centrum, Zaandam

Unknown

Rijnstate, Arnhem

All Listed Sponsors
collaborator

Noordwest Ziekenhuisgroep

OTHER

collaborator

Rijnstate

UNKNOWN

collaborator

Tergooiziekenhuizen locatie Hilversum

UNKNOWN

collaborator

Ziekenhuis Amstelland

OTHER

lead

Amsterdam UMC, location VUmc

OTHER

NCT02135510 - MEtoclopramide, DExamethasone or Axoli to Prevent or Delay Chemotherapy-induced Nausea and Vomiting in Moderately Emetogenic Non-AC-based Chemotherapy | Biotech Hunter | Biotech Hunter